Reckitt to pay $1.4 billion to end long-running Indivior probes

(Reuters) - Britain's Reckitt Benckiser has agreed to pay up to $1.4 billion (£1.1 billion) to resolve all U.S. federal investigations into the sales and marketing of an opioid addiction treatment by its former prescription pharmaceuticals business Indivior .While the settlement is significantly higher than the $400 million that the consumer goods group had set aside to cover the cost of the investigations, analysts said it lifted a cloud that has been hanging over the company for years...